Drugs Made In America Acquisition II Corp.
DMII
$10.01
$0.000.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 200.00 | 315.10K | 4.40K | 7.00K | |
| Total Receivables | -- | 566.30K | 2.60K | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 25.80K | 15.00K | 4.60K | 4.60K | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | |
| Total Current Assets | 26.00K | 896.40K | 11.60K | 11.60K | |
|
|
|||||
| Total Current Assets | 26.00K | 896.40K | 11.60K | 11.60K | |
| Net Property, Plant & Equipment | -- | -- | -- | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 504.93M | 500.11M | 101.80K | 93.50K | |
| Total Assets | 504.96M | 501.01M | 113.40K | 105.10K | |
|
|
|||||
| Total Accounts Payable | 99.40K | 4.60K | -- | -- | |
| Total Accrued Expenses | 88.30K | 5.80K | 2.20K | 11.30K | |
| Short-term Debt | -- | -- | 297.30K | 250.10K | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Liabilities | 113.20K | 666.90K | 28.10K | 19.80K | |
| Total Other Current Liabilities | 113.20K | 666.90K | 28.10K | 19.80K | |
| Total Current Liabilities | 300.90K | 677.30K | 327.50K | 281.10K | |
|
|
|||||
| Total Current Liabilities | 300.90K | 677.30K | 327.50K | 281.10K | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | 297.30K | 250.10K | |
| Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | 522.43M | 517.61M | -- | -- | |
| Total Liabilities | 522.73M | 518.29M | 327.50K | 281.10K | |
|
|
|||||
| Common Stock & APIC | 1.40K | 1.60K | 35.00K | 35.00K | |
| Retained Earnings | -17.78M | -17.28M | -249.10K | -211.00K | |
| Treasury Stock & Other | -- | -- | -- | -- | |
| Total Common Equity | -17.77M | -17.28M | -214.10K | -176.00K | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | -17.77M | -17.28M | -214.10K | -176.00K | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | -17.77M | -17.28M | -214.10K | -176.00K | |
|
|
|||||